Literature DB >> 35949778

An Unusual Side Effect of the COVID-19 Vaccine: A Possible Trigger of Polymyalgia Rheumatica.

Anam Ahmad1, Donica L Baker2.   

Abstract

Polymyalgia rheumatica (PMR) is characterized by myalgia and severe stiffness with decreased range of motion in the shoulder and pelvic girdles. The efficacy of the BNT 162b2 Pfizer vaccine has been proven and has been well-tolerated by patients; however, some instances of PMR have been reported after the COVID-19 vaccine. We are writing a case of a new-onset PMR in a 72-year-old woman with typical findings after receiving a booster dose of the BNT 162b2 Pfizer vaccine. This case report highlights that PMR should be in the differential diagnosis of myalgias caused by the vaccine.
Copyright © 2022, Ahmad et al.

Entities:  

Keywords:  bnt162b2 vaccine; covid-19 vaccine; myalgia; pmr; side effect of vaccine

Year:  2022        PMID: 35949778      PMCID: PMC9356652          DOI: 10.7759/cureus.26617

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  14 in total

Review 1.  Polymyalgia rheumatica and giant-cell arteritis.

Authors:  Carlo Salvarani; Fabrizio Cantini; Luigi Boiardi; Gene G Hunder
Journal:  N Engl J Med       Date:  2002-07-25       Impact factor: 91.245

2.  Polymyalgia rheumatica.

Authors:  C Salvarani; L Boiardi; L Macchioni; I Olivieri; I Portioli
Journal:  Lancet       Date:  1996-08-24       Impact factor: 79.321

3.  Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) demonstrates distinct autoimmune and autoinflammatory disease associations according to the adjuvant subtype: Insights from an analysis of 500 cases.

Authors:  Abdulla Watad; Nicola Luigi Bragazzi; Dennis McGonagle; Mohammed Adawi; Charlie Bridgewood; Giovanni Damiani; Jaume Alijotas-Reig; Enrique Esteve-Valverde; Mariana Quaresma; Howard Amital; Yehuda Shoenfeld
Journal:  Clin Immunol       Date:  2019-03-25       Impact factor: 3.969

Review 4.  Relapse of polymyalgia rheumatica following adjuvanted influenza vaccine: A case-based review.

Authors:  Margaret F Bassendine; Simon H Bridge
Journal:  Eur J Rheumatol       Date:  2019-12-16

5.  2012 Provisional classification criteria for polymyalgia rheumatica: a European League Against Rheumatism/American College of Rheumatology collaborative initiative.

Authors:  Bhaskar Dasgupta; Marco A Cimmino; Hilal Maradit Kremers; Wolfgang A Schmidt; Michael Schirmer; Carlo Salvarani; Artur Bachta; Christian Dejaco; Christina Duftner; Hanne Slott Jensen; Pierre Duhaut; Gyula Poór; Novák Pál Kaposi; Peter Mandl; Peter V Balint; Zsuzsa Schmidt; Annamaria Iagnocco; Carlotta Nannini; Fabrizio Cantini; Pierluigi Macchioni; Nicolò Pipitone; Montserrat Del Amo; Georgina Espígol-Frigolé; Maria C Cid; Víctor M Martínez-Taboada; Elisabeth Nordborg; Haner Direskeneli; Sibel Zehra Aydin; Khalid Ahmed; Brian Hazleman; Barbara Silverman; Colin Pease; Richard J Wakefield; Raashid Luqmani; Andy Abril; Clement J Michet; Ralph Marcus; Neil J Gonter; Mehrdad Maz; Rickey E Carter; Cynthia S Crowson; Eric L Matteson
Journal:  Arthritis Rheum       Date:  2012-04

6.  Long-term follow-up of polymyalgia rheumatica: evidence for synovitis.

Authors:  L A Healey
Journal:  Semin Arthritis Rheum       Date:  1984-05       Impact factor: 5.532

7.  Giant cell arteritis, polymyalgia rheumatica, and viral hypotheses: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes.

Authors:  P Duhaut; S Bosshard; A Calvet; L Pinede; S Demolombe-Rague; C Dumontet; R Loire; D Seydoux; J Ninet; J Pasquier; M Aymard
Journal:  J Rheumatol       Date:  1999-02       Impact factor: 4.666

Review 8.  Recent advances in the diagnosis and treatment of polymyalgia rheumatica.

Authors:  Francesco Muratore; Giulia Pazzola; Nicolò Pipitone; Carlo Salvarani
Journal:  Expert Rev Clin Immunol       Date:  2016-05-06       Impact factor: 4.473

9.  Side effects of BNT162b2 mRNA COVID-19 vaccine: A randomized, cross-sectional study with detailed self-reported symptoms from healthcare workers.

Authors:  Renuka A K Kadali; Ravali Janagama; Sharanya Peruru; Srikrishna V Malayala
Journal:  Int J Infect Dis       Date:  2021-04-15       Impact factor: 3.623

10.  SARS-CoV-2, polymyalgia rheumatica and giant cell arteritis: COVID-19 vaccine shot as a trigger? Comment on: "Can SARS-CoV-2 trigger relapse of polymyalgia rheumatica?" by Manzo et al. Joint Bone Spine 2021;88:105150.

Authors:  Simon Cadiou; Aleth Perdriger; Samuel Ardois; Jean-David Albert; Olivia Berthoud; Alain Lescoat; Pascal Guggenbuhl; François Robin
Journal:  Joint Bone Spine       Date:  2021-09-29       Impact factor: 4.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.